Variability in Donor-Specific Alloantibody Production After Transplantation

Transplantation Proceedings

Volumn 39, Issue 9, 2007, Pages 2715-2717

  Banasik, M ^a   Boratynska M ^a   Nowakowska, B ^b   Halon A ^a   Koscielska Kasprzak K ^a   Drulis Fajdasz, D ^a   Patrzalek D ^a   Weyde, W ^a   Klinger, M ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; COMPLEMENT COMPONENT C4D; CREATININE;

ACUTE GRAFT REJECTION; ADULT; ALLOIMMUNITY; ANTIBODY PRODUCTION; ARTICLE; CLINICAL ARTICLE; COMPLEMENT DEPENDENT CYTOTOXICITY; COMPLEMENT DEPOSITION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; HUMAN; INCIDENCE; KIDNEY ALLOGRAFT; KIDNEY ALLOGRAFT REJECTION; KIDNEY DYSFUNCTION; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RENAL GRAFT DYSFUNCTION;

ADULT; CADAVER; CREATININE; FEMALE; FOLLOW-UP STUDIES; HUMANS; ISOANTIBODIES; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RENAL REPLACEMENT THERAPY; TIME FACTORS; TISSUE DONORS;

EID: 36048969817     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2007.08.054     Document Type: Article

References (15)

1. Terasaki P.I. Humoral theory of transplantation. Am J Transplant 3 (2003) 665
2. Terasaki P.I., and Cai J. Humoral theory of transplantation: further evidence. Curr Opin Immunol 17 (2005) 541
3. Feucht H.E., Schneeberger H., Hillebrand G., et al. Capillary deposition of C4d complement fragment and early renal graft loss. Kidney Int 43 (1993) 1333
4. Halloran P.F., Schlaut J., Solez K., et al. The significance of the anti-class I antibody response. II. Clinical and pathologic features of renal transplants with anti-class I-like antibody. Transplantation 53 (1992) 550
5. Colvin R.B., and Smith R.N. Antibody-mediated organ-allograft rejection. Nat Rev Immunol 5 (2005) 807
6. Rahimi S., Qian Z., Layton J., et al. Non-complement- and complement-activating antibodies synergize to cause rejection of cardiac allografts. Am J Transplant 4 (2004) 326
7. Wahrmann M., Exner M., Schillinger M., et al. Pivotal role of complement-fixing HLA alloantibodies in presensitized kidney allograft recipients. Am J Transplant 6 (2006) 1033
8. Terasaki P.I., and Ozawa M. Predictive value of HLA antibodies and serum creatinine in chronic rejection: results of a 2-year prospective trial. Transplantation 80 (2005) 1194
9. Banasik M., and Klinger M. Chronic allograft nephropathy-immunologic and nonimmunologic factors. Ann Transplant 11 (2006) 7
10. El-Awar N., Terasaki P.I., Lazda V., et al. Almost all patients who are waiting for a regraft of a kidney transplant have anti-HLA antibodies. Transplant Proc 34 (2002) 2531
11. Harmer A.W., Koffman C.G., Heads A.J., et al. Sensitization to HLA antigens occurs in 95% of primary renal transplant rejections. Transplant Proc 27 (1995) 666
12. Carter V., Shenton B., Jaques B., et al. Vimentin antibodies: a non-HLA antibody as a potential risk factor in renal transplantation. Transplant Proc 37 (2005) 654
13. Terasaki P.I., and Ozawa M. Predicting kidney graft failure by HLA antibodies: a prospective trial. Am J Transplant 4 (2004) 438
14. Tinckam K.J., and Chandraker A. Mechanism and role of LA and non-HLA alloantibodies. Clin J Am Soc Nephrol 1 (2006) 404
15. Gao Z.H., McAlister V.C., Wright Jr. J.R., et al. Immunoglobulin-G subclass antidonor reactivity in transplant recipients. Liver Transpl 10 (2004) 1055